Syncom Formulations (India) Limited (SYNCOMF) — Financial Results | 25 June 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Syncom Formulations (India) Limited announced that its trading window will close on 1 July 2026 until 48 hours after the unaudited financial results for the quarter ended 30 June 2026 are declared, requiring designated persons to refrain from trading and PAN freezing by CDSL, with board approval of results to follow in due course.

📄 View Original Announcement (PDF)

About Syncom Formulations (India) Limited (SYNCOMF)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹2,010.66 Cr P/E: 23.5 ROE: 25.0% ROCE: 32.9%

View full SYNCOMF stock details →

📡 Get AI alerts when SYNCOMF files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SYNCOMF — Free

📊 More SYNCOMF filings

See all SYNCOMF filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SYNCOMF files new disclosures

Track SYNCOMF filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SYNCOMF — Free

Free account · 2 AI queries/day